Kronos Bio KRON Stock
Kronos Bio Price Chart
Kronos Bio KRON Financial and Trading Overview
| Kronos Bio stock price | 1.03 USD |
| Previous Close | 1.06 USD |
| Open | 1.04 USD |
| Bid | 1.22 USD x 2200 |
| Ask | 1.23 USD x 900 |
| Day's Range | 0.99 - 1.13 USD |
| 52 Week Range | 0.73 - 2.84 USD |
| Volume | 282.75K USD |
| Avg. Volume | 243.84K USD |
| Market Cap | 64.73M USD |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.95 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.75 USD |
KRON Valuation Measures
| Enterprise Value | -92439664 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.55778897 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 16.174742 |
| Price/Book (mrq) | 0.36156353 |
| Enterprise Value/Revenue | -23.098 |
| Enterprise Value/EBITDA | 0.734 |
Trading Information
Kronos Bio Stock Price History
| Beta (5Y Monthly) | 1.55 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 2.84 USD |
| 52 Week Low | 0.73 USD |
| 50-Day Moving Average | 1.07 USD |
| 200-Day Moving Average | 1.52 USD |
KRON Share Statistics
| Avg. Volume (3 month) | 243.84K USD |
| Avg. Daily Volume (10-Days) | 462.67K USD |
| Shares Outstanding | 58.32M |
| Float | 44.61M |
| Short Ratio | 10.14 |
| % Held by Insiders | 16.22% |
| % Held by Institutions | 56.54% |
| Shares Short | 2.72M |
| Short % of Float | 6.03% |
| Short % of Shares Outstanding | 4.66% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3688.65% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.83% |
| Return on Equity (ttm) | -53.38% |
Income Statement
| Revenue (ttm) | 4M USD |
| Revenue Per Share (ttm) | 0.07 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -125936000 USD |
| Net Income Avi to Common (ttm) | -119135000 USD |
| Diluted EPS (ttm) | -2.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 186.71M USD |
| Total Cash Per Share (mrq) | 3.2 USD |
| Total Debt (mrq) | 29.54M USD |
| Total Debt/Equity (mrq) | 16.54 USD |
| Current Ratio (mrq) | 7.462 |
| Book Value Per Share (mrq) | 3.07 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -76086000 USD |
| Levered Free Cash Flow (ttm) | -45007000 USD |
Profile of Kronos Bio
| Country | United States |
| State | CA |
| City | San Mateo |
| Address | 1300 South El Camino Real |
| ZIP | 94402 |
| Phone | 650 781 5200 |
| Website | https://kronosbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 99 |
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial; and Lanraplenib, a next-generation SYK inhibitor to treat the patients with relapsed/refractory FLT3-mutated acute myeloid leukemia. The company was incorporated in 2017 and is headquartered in San Mateo, California.
Q&A For Kronos Bio Stock
What is a current KRON stock price?
Kronos Bio KRON stock price today per share is 1.03 USD.
How to purchase Kronos Bio stock?
You can buy KRON shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kronos Bio?
The stock symbol or ticker of Kronos Bio is KRON.
Which industry does the Kronos Bio company belong to?
The Kronos Bio industry is Biotechnology.
How many shares does Kronos Bio have in circulation?
The max supply of Kronos Bio shares is 65.94M.
What is Kronos Bio Price to Earnings Ratio (PE Ratio)?
Kronos Bio PE Ratio is now.
What was Kronos Bio earnings per share over the trailing 12 months (TTM)?
Kronos Bio EPS is -1.95 USD over the trailing 12 months.
Which sector does the Kronos Bio company belong to?
The Kronos Bio sector is Healthcare.
Kronos Bio KRON included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}